New intranasal influenza vaccine triggers robust immunity with significantly less antigen

October 29, 2008

A single administration of a novel, nasally delivered influenza vaccine elicited immune responses in ferrets that were more than 20 times higher than those generated by two injections of the currently approved vaccines, according to a study by NanoBio Corporation. The new vaccine used only half the standard antigen dose to produce this effect.

Results of the study are being presented today at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)/Infectious Diseases Society of America (IDSA) 46th annual meeting in Washington, D.C.

The company's nasal vaccines exert adjuvant activity without the need for pro-inflammatory materials, toxins or cytokines.

"Our nanoemulsion-based intranasal vaccine adjuvant system represents a paradigm shift in vaccinology. It can be used to safely deliver multiple antigen types directly into the lining of the nasal mucosa, which is rich in dendritic cells that present the antigen(s) to the immune system," said James R. Baker, Jr., M.D., founder and chairman of NanoBio Corp. "The nanoemulsion adjuvant uniquely interacts with these cells to trigger unparalleled mucosal and systemic immunity."

In the study, ferrets received 7.5, 15 and 45 micrograms of nanoemulsion-adjuvanted influenza vaccine (n=12 ferrets/dose). All three doses produced antibody responses substantially higher than those triggered by the standard intramuscular vaccine. The ferrets, which represent the most relevant influenza animal model for humans, were then challenged with live influenza virus, and all were protected.

"A large, unmet medical need still exists for protecting people from influenza infection," Baker said. "The robust immunity and antigen-sparing capability demonstrated in this study are especially important for addressing this unmet need, as are the demands for a vaccine that would protect people in the face of a flu pandemic."

NanoBio plans to begin a phase 1 clinical study for seasonal influenza in the first half of 2009 and is currently initiating preclinical studies in pandemic flu.

MedThink Communications

---

---

	Keeping Our Adult Patients Healthy and Active: The Role of Vaccines Across the Lifespan (The Physician and Sportsmedicine) by JTE Multimedia The Centers for Disease Control and Prevention (CDC) recommend vaccinations from birth through adulthood for lifetime protection against many diseases and infections. Healthy, active adults need to be vaccinated for personal protection against infection as well as associated health benefits (eg, ability to maintain their daily activities). Immunization also reduces the risk of an individual transmitting infection to others, thereby conferring protection to his or her entire community. In the United States, influenza and pertussis (part of the trivalent Tdap) vaccines are recommended for every adult. There are other important vaccines for adults: the human papillomavirus (HPV) vaccine is recommended for every adult female aged up to 26 years, shingles vaccine is recommended for all adults...
	Influenza vaccines do not trigger MS relapses: IOM report on adults.(Clinical Rounds): An article from: Family Practice News by Sally Koch Kubetin (Author) This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2004. The length of the article is 555 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Influenza vaccines do not trigger MS relapses: IOM report on adults.(Clinical Rounds) Author: Sally Koch Kubetin Publication: Family Practice News (Magazine/Journal) Date: February 1, 2004 Publisher: International Medical News Group Volume: 34 Issue: 3 Page: 52(1) Distributed by Thomson...
	Influenza vaccine production to exceed 2003 supply.(News): An article from: Skin & Allergy News by Patrice G.W. Norton (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on August 1, 2004. The length of the article is 665 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Influenza vaccine production to exceed 2003 supply.(News) Author: Patrice G.W. Norton Publication: Skin & Allergy News (Magazine/Journal) Date: August 1, 2004 Publisher: International Medical News Group Volume: 35 Issue: 8 Page: 19(1) Distributed by Thomson...
	Flu vaccine has little effect on otitis media frequency. (Study of 786 Children).: An article from: Family Practice News by Michele G. Sullivan (Author) This digital document is an article from Family Practice News, published by International Medical News Group on August 15, 2002. The length of the article is 712 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Flu vaccine has little effect on otitis media frequency. (Study of 786 Children). Author: Michele G. Sullivan Publication: Family Practice News (Magazine/Journal) Date: August 15, 2002 Publisher: International Medical News Group Volume: 32 Issue: 16 Page: 30(1) Distributed by Thomson...
	HHS orders 2 million avian flu vaccine doses.(News): An article from: Skin & Allergy News by Michele G. Sullivan (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on December 1, 2004. The length of the article is 607 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: HHS orders 2 million avian flu vaccine doses.(News) Author: Michele G. Sullivan Publication: Skin & Allergy News (Magazine/Journal) Date: December 1, 2004 Publisher: International Medical News Group Volume: 35 Issue: 12 Page: 4(1) Distributed by Thomson...
	Developing Flu Vaccines (Freestyle Express: Science Missions) by Michael Burgan (Author) The Flu is much more than a bad cold. It can kill. How does it spread so quickly? How are vaccines created? Find out in this fascinating book.
	Vaccines for Pandemic Influenza (Current Topics in Microbiology and Immunology) by Richard W. Compans (Editor), Walter A. Orenstein (Editor) The recent outbreak of disease caused by a novel H1N1 virus has focused global attention on the threat of a new influenza pandemic. Recent years have also seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans resulting in numerous fatalities. The rapid expansion in the geographic distribution of these novel viruses raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have limited...
	A Warning Shot: Influenza and the 2004 Flu Vaccine by Tim Brookes (Author) A Warning Shot is a story of paradoxes. It is about the failure of government regulatory oversight as well as the heroic efforts of public health officials to respond to the crisis. It is the story of catastrophic production failure at one company and the work of others to fill the void. It is a tale about the failure of national leadership to protect our nation’s vaccine supply at a time when many of these same leaders were taking great care to prepare for a potential pandemic influenza.
	Influenza Pandemic: Response and Vaccine Challenges (Public Health in the 21st Century) by Adrian J. Buckman (Author), Adrian J. Buckman (Editor) On 11 June 2009, in response to the global spread of a new strain of H1N1 influenza, the World Health Organization (WHO) declared the outbreak to be an influenza pandemic, the first since 1968. When the outbreak began, U.S. official adopted a response posture under the overall coordination of the Secretary of Homeland Security. This book provides a synopsis of key events in the H1N1 pandemic response, followed by information about selected federal emergency management authorities and actions taken by DHS, HHS, and state and local authorities.
	The 2009-2014 World Outlook for Influenza Vaccines by Icon Group (Author) This econometric study covers the world outlook for influenza vaccines across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized...